More than 3.5 million people in the UK could now be living with an eating disorder, a figure that dramatically reshapes ...

Starmer’s former deputy has returned to frontline politics as Housing Secretary – despite being sidelined by close allies of ...

A new generation of therapies aims to intervene at a recently discovered gap between the disease’s molecular march and its ...

Scientists discovered that a key brain signal may have been pointing researchers in the wrong direction, potentially changing ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today ...

Levacetylleucine (Aqneursa) improved neurologic symptoms and functioning in adults and children with ataxia-telangiectasia in ...

Joubert syndrome (JS) is a rare ciliopathy characterised by the molar tooth sign on brain MRI, cerebellar vermis hypoplasia, hypotonia and developmental delay. We report an elementary school-aged boy ...

AUSTIN, Texas, June 18, 2026--(BUSINESS WIRE)--IntraBio Inc. today announced that results from its pivotal Phase III clinical trial evaluating levacetylleucine for the treatment of ...

IntraBio Inc. today announced that results from its pivotal Phase III clinical trial evaluating levacetylleucine for the treatment of Ataxia-Telangiectasia (A-T) have been published in The Lancet ...